{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,13]],"date-time":"2026-09-13T07:57:11Z","timestamp":1789286231939,"version":"build-2803163510"},"reference-count":88,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T00:00:00Z","timestamp":1741132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T00:00:00Z","timestamp":1741132800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-025-57520-3","type":"journal-article","created":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T15:58:57Z","timestamp":1741190337000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Pathogenic germline variants in Chinese pancreatic adenocarcinoma patients"],"prefix":"10.1038","volume":"16","author":[{"given":"Xiaoyi","family":"Yin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5539-5893","authenticated-orcid":false,"given":"Huan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingchen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunming","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0769-1874","authenticated-orcid":false,"given":"Qi","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1020-0236","authenticated-orcid":false,"given":"Shiwei","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9532-4582","authenticated-orcid":false,"given":"Xiongfei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4638-1462","authenticated-orcid":false,"given":"Xiaohan","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suizhi","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meilong","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuenan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiawei","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoxiao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yikai","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Penghao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Jing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kailian","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yijie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhijian","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiangzu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianglong","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengxian","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunguang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1821-2741","authenticated-orcid":false,"given":"Dong","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9295-1951","authenticated-orcid":false,"given":"Haojie","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongbo","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7973-3930","authenticated-orcid":false,"given":"Jing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6713-1185","authenticated-orcid":false,"given":"Gang","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,5]]},"reference":[{"key":"57520_CR1","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray, F. et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 68, 394\u2013424 (2018).","journal-title":"CA Cancer J. Clin."},{"key":"57520_CR2","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/nature11547","volume":"491","author":"AV Biankin","year":"2012","unstructured":"Biankin, A. V. et al. Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes. Nature 491, 399\u2013405 (2012).","journal-title":"Nature"},{"key":"57520_CR3","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/nature16965","volume":"531","author":"P Bailey","year":"2016","unstructured":"Bailey, P. et al. Genomic analyses identify molecular subtypes of pancreatic cancer. Nature 531, 47\u201352 (2016).","journal-title":"Nature"},{"key":"57520_CR4","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms7744","volume":"6","author":"AK Witkiewicz","year":"2015","unstructured":"Witkiewicz, A. K. et al. Whole-exome sequencing of pancreatic cancer defines genetic diversity and therapeutic targets. Nat. Commun. 6, 6744 (2015).","journal-title":"Nat. Commun."},{"key":"57520_CR5","doi-asserted-by":"publisher","first-page":"5031","DOI":"10.1016\/j.cell.2021.08.023","volume":"184","author":"L Cao","year":"2021","unstructured":"Cao, L. et al. Proteogenomic characterization of pancreatic ductal adenocarcinoma. Cell 184, 5031\u20135052 e5026 (2021).","journal-title":"Cell"},{"key":"57520_CR6","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1001\/jamaoncol.2021.0006","volume":"7","author":"M Javle","year":"2021","unstructured":"Javle, M. et al. Olaparib monotherapy for previously treated pancreatic cancer with DNA damage repair genetic alterations other than germline BRCA variants: findings from 2 phase 2 nonrandomized clinical trials. JAMA Oncol. 7, 693\u2013699, (2021).","journal-title":"JAMA Oncol."},{"key":"57520_CR7","doi-asserted-by":"publisher","DOI":"10.1136\/esmoopen-2019-000578","volume":"5","author":"I Pokataev","year":"2020","unstructured":"Pokataev, I. et al. Efficacy of platinum-based chemotherapy and prognosis of patients with pancreatic cancer with homologous recombination deficiency: comparative analysis of published clinical studies. ESMO Open 5, e000578 (2020).","journal-title":"ESMO Open"},{"key":"57520_CR8","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1126\/science.aan6733","volume":"357","author":"DT Le","year":"2017","unstructured":"Le, D. T. et al. Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade. Science 357, 409\u2013413 (2017).","journal-title":"Science"},{"key":"57520_CR9","doi-asserted-by":"publisher","first-page":"2509","DOI":"10.1056\/NEJMoa1500596","volume":"372","author":"DT Le","year":"2015","unstructured":"Le, D. T. et al. PD-1 blockade in tumors with mismatch-repair deficiency. N. Eng. J. Med. 372, 2509\u20132520 (2015).","journal-title":"N. Eng. J. Med."},{"key":"57520_CR10","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1056\/NEJMoa1903387","volume":"381","author":"T Golan","year":"2019","unstructured":"Golan, T. et al. Maintenance olaparib for germline BRCA-mutated metastatic pancreatic cancer. N. Engl. J. Med. 381, 317\u2013327 (2019).","journal-title":"N. Engl. J. Med."},{"key":"57520_CR11","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1038\/nrgastro.2009.177","volume":"6","author":"S Raimondi","year":"2009","unstructured":"Raimondi, S., Maisonneuve, P. & Lowenfels, A. B. Epidemiology of pancreatic cancer: an overview. Nat. Rev. Gastroenterol. Hepatol. 6, 699\u2013708 (2009).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"57520_CR12","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.yasu.2010.05.011","volume":"44","author":"RH Hruban","year":"2010","unstructured":"Hruban, R. H., Canto, M. I., Goggins, M., Schulick, R. & Klein, A. P. Update on familial pancreatic cancer. Adv. Surg. 44, 293\u2013311 (2010).","journal-title":"Adv. Surg."},{"key":"57520_CR13","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1200\/JCO.2006.09.2452","volume":"25","author":"W Wang","year":"2007","unstructured":"Wang, W. et al. PancPRO: risk assessment for individuals with a family history of pancreatic cancer. J. Clin. Oncol. 25, 1417\u20131422 (2007).","journal-title":"J. Clin. Oncol."},{"key":"57520_CR14","doi-asserted-by":"publisher","first-page":"2634","DOI":"10.1158\/0008-5472.CAN-03-3823","volume":"64","author":"AP Klein","year":"2004","unstructured":"Klein, A. P. et al. Prospective risk of pancreatic cancer in familial pancreatic cancer kindreds. Cancer Res. 64, 2634\u20132638 (2004).","journal-title":"Cancer Res."},{"key":"57520_CR15","doi-asserted-by":"publisher","first-page":"4382","DOI":"10.1002\/cncr.29664","volume":"121","author":"EE Salo-Mullen","year":"2015","unstructured":"Salo-Mullen, E. E. et al. Identification of germline genetic mutations in patients with pancreatic cancer. Cancer 121, 4382\u20134388 (2015).","journal-title":"Cancer"},{"key":"57520_CR16","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1097\/MPA.0000000000001136","volume":"47","author":"W Zhan","year":"2018","unstructured":"Zhan, W., Shelton, C. A., Greer, P. J., Brand, R. E. & Whitcomb, D. C. Germline variants and risk for pancreatic cancer: a systematic review and emerging concepts. Pancreas 47, 924\u2013936 (2018).","journal-title":"Pancreas"},{"key":"57520_CR17","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.cell.2018.03.039","volume":"173","author":"KL Huang","year":"2018","unstructured":"Huang, K. L. et al. Pathogenic germline variants in 10,389 adult cancers. Cell 173, 355\u2013370 e314 (2018).","journal-title":"Cell"},{"key":"57520_CR18","doi-asserted-by":"publisher","first-page":"1790","DOI":"10.1001\/jama.2009.1529","volume":"302","author":"F Kastrinos","year":"2009","unstructured":"Kastrinos, F. et al. Risk of pancreatic cancer in families with lynch syndrome. Jama 302, 1790\u20131795 (2009).","journal-title":"Jama"},{"key":"57520_CR19","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1158\/2159-8290.CD-11-0194","volume":"2","author":"NJ Roberts","year":"2012","unstructured":"Roberts, N. J. et al. ATM mutations in patients with hereditary pancreatic cancer. Cancer Discov. 2, 41\u201346 (2012).","journal-title":"Cancer Discov."},{"key":"57520_CR20","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1038\/gim.2014.153","volume":"17","author":"DB Zhen","year":"2015","unstructured":"Zhen, D. B. et al. BRCA1, BRCA2, PALB2, and CDKN2A mutations in familial pancreatic cancer: a PACGENE study. Genet. Med. 17, 569\u2013577 (2015).","journal-title":"Genet. Med."},{"key":"57520_CR21","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1158\/2159-8290.CD-15-0402","volume":"6","author":"NJ Roberts","year":"2016","unstructured":"Roberts, N. J. et al. Whole genome sequencing defines the genetic heterogeneity of familial pancreatic cancer. Cancer Discov. 6, 166\u2013175 (2016).","journal-title":"Cancer Discov."},{"key":"57520_CR22","doi-asserted-by":"publisher","first-page":"D835","DOI":"10.1093\/nar\/gkz972","volume":"48","author":"MJ Landrum","year":"2020","unstructured":"Landrum, M. J. et al. ClinVar: improvements to accessing data. Nucleic Acids Res. 48, D835\u2013D844 (2020).","journal-title":"Nucleic Acids Res."},{"key":"57520_CR23","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.ajhg.2017.01.004","volume":"100","author":"Q Li","year":"2017","unstructured":"Li, Q. & Wang, K. InterVar: Clinical interpretation of genetic variants by the 2015 ACMG-AMP guidelines. Am. J. Hum. Genet. 100, 267\u2013280 (2017).","journal-title":"Am. J. Hum. Genet."},{"key":"57520_CR24","doi-asserted-by":"publisher","first-page":"2401","DOI":"10.1001\/jama.2018.6228","volume":"319","author":"C Hu","year":"2018","unstructured":"Hu, C. et al. Association between inherited germline mutations in cancer predisposition genes and risk of pancreatic cancer. JAMA 319, 2401\u20132409 (2018).","journal-title":"JAMA"},{"key":"57520_CR25","doi-asserted-by":"publisher","first-page":"3124","DOI":"10.1200\/JCO.2014.59.7401","volume":"33","author":"S Holter","year":"2015","unstructured":"Holter, S. et al. Germline BRCA mutations in a large clinic-based cohort of patients with pancreatic adenocarcinoma. J. Clin. Oncol. 33, 3124\u20133129 (2015).","journal-title":"J. Clin. Oncol."},{"key":"57520_CR26","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1001\/jama.2017.11137","volume":"318","author":"D Mandelker","year":"2017","unstructured":"Mandelker, D. et al. Mutation detection in patients with advanced cancer by universal sequencing of cancer-related genes in tumor and normal DNA vs guideline-based germline testing. JAMA 318, 825\u2013835 (2017).","journal-title":"JAMA"},{"key":"57520_CR27","doi-asserted-by":"publisher","first-page":"3382","DOI":"10.1200\/JCO.2017.72.3502","volume":"35","author":"K Shindo","year":"2017","unstructured":"Shindo, K. et al. Deleterious germline mutations in patients with apparently sporadic pancreatic adenocarcinoma. J. Clin. Oncol. 35, 3382\u20133390 (2017).","journal-title":"J. Clin. Oncol."},{"key":"57520_CR28","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/nature21063","volume":"543","author":"A Scarpa","year":"2017","unstructured":"Scarpa, A. et al. Whole-genome landscape of pancreatic neuroendocrine tumours. Nature 543, 65\u201371 (2017).","journal-title":"Nature"},{"key":"57520_CR29","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1200\/JCO.19.01890","volume":"38","author":"T Golan","year":"2020","unstructured":"Golan, T. et al. Geographic and ethnic heterogeneity of germline BRCA1 or BRCA2 mutation prevalence among patients with metastatic pancreatic cancer screened for entry into the POLO trial. J. Clin. Oncol. 38, 1442\u20131454 (2020).","journal-title":"J. Clin. Oncol."},{"key":"57520_CR30","doi-asserted-by":"publisher","first-page":"e2148721","DOI":"10.1001\/jamanetworkopen.2021.48721","volume":"5","author":"L Yin","year":"2022","unstructured":"Yin, L. et al. Prevalence of germline sequence variations among patients with pancreatic cancer in China. JAMA Netw. Open 5, e2148721 (2022).","journal-title":"JAMA Netw. Open"},{"key":"57520_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2020.103033","volume":"60","author":"K Mizukami","year":"2020","unstructured":"Mizukami, K. et al. Genetic characterization of pancreatic cancer patients and prediction of carrier status of germline pathogenic variants in cancer-predisposing genes. EBioMedicine 60, 103033 (2020).","journal-title":"EBioMedicine"},{"key":"57520_CR32","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-022-02279-9","volume":"17","author":"Q Ni","year":"2022","unstructured":"Ni, Q. et al. Systematic estimation of cystic fibrosis prevalence in Chinese and genetic spectrum comparison to Caucasians. Orphanet J. Rare Dis. 17, 129 (2022).","journal-title":"Orphanet J. Rare Dis."},{"key":"57520_CR33","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1038\/s41424-018-0069-5","volume":"9","author":"WB Zou","year":"2018","unstructured":"Zou, W. B. et al. SPINK1, PRSS1, CTRC, and CFTR genotypes influence disease onset and clinical outcomes in chronic pancreatitis. Clin. Transl. Gastroenterol. 9, 204 (2018).","journal-title":"Clin. Transl. Gastroenterol."},{"key":"57520_CR34","unstructured":"Organization, W. H. Report of a joint meeting of WHO\/ECFTN\/ICF (M) A\/ECFS. https:\/\/iris.who.int\/handle\/10665\/68702 (2002)."},{"key":"57520_CR35","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1136\/gut.2005.074534","volume":"54","author":"R McWilliams","year":"2005","unstructured":"McWilliams, R. et al. Cystic fibrosis transmembrane regulator gene carrier status is a risk factor for young onset pancreatic adenocarcinoma. Gut 54, 1661\u20131662 (2005).","journal-title":"Gut"},{"key":"57520_CR36","doi-asserted-by":"publisher","first-page":"652","DOI":"10.4161\/cbt.2.6.530","volume":"2","author":"H Matsubayashi","year":"2003","unstructured":"Matsubayashi, H. et al. Polymorphisms of SPINK1 N34S and CFTR in patients with sporadic and familial pancreatic cancer. Cancer Biol. Ther. 2, 652\u2013655 (2003).","journal-title":"Cancer Biol. Ther."},{"key":"57520_CR37","doi-asserted-by":"publisher","first-page":"4983","DOI":"10.1158\/1078-0432.CCR-13-0209","volume":"19","author":"G Zhang","year":"2013","unstructured":"Zhang, G. et al. Integration of metabolomics and transcriptomics revealed a fatty acid network exerting growth inhibitory effects in human pancreatic cancer. Clin. Cancer Res. 19, 4983\u20134993 (2013).","journal-title":"Clin. Cancer Res."},{"key":"57520_CR38","doi-asserted-by":"publisher","first-page":"2823","DOI":"10.1111\/j.1582-4934.2008.00289.x","volume":"12","author":"C Pilarsky","year":"2008","unstructured":"Pilarsky, C. et al. Activation of Wnt signalling in stroma from pancreatic cancer identified by gene expression profiling. J. Cell Mol. Med. 12, 2823\u20132835 (2008).","journal-title":"J. Cell Mol. Med."},{"key":"57520_CR39","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1038\/nm.2344","volume":"17","author":"EA Collisson","year":"2011","unstructured":"Collisson, E. A. et al. Subtypes of pancreatic ductal adenocarcinoma and their differing responses to therapy. Nat. Med. 17, 500\u2013503 (2011).","journal-title":"Nat. Med."},{"key":"57520_CR40","doi-asserted-by":"publisher","first-page":"3513","DOI":"10.1093\/nar\/gkaa089","volume":"48","author":"M NandyMazumdar","year":"2020","unstructured":"NandyMazumdar, M. et al. Looping of upstream cis-regulatory elements is required for CFTR expression in human airway epithelial cells. Nucleic acids Res. 48, 3513\u20133524 (2020).","journal-title":"Nucleic acids Res."},{"key":"57520_CR41","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s00018-016-2391-y","volume":"74","author":"V Saint-Criq","year":"2017","unstructured":"Saint-Criq, V. & Gray, M. A. Role of CFTR in epithelial physiology. Cell Mol. Life Sci. 74, 93\u2013115 (2017).","journal-title":"Cell Mol. Life Sci."},{"key":"57520_CR42","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1097\/MPA.0000000000001145","volume":"47","author":"IM Cazacu","year":"2018","unstructured":"Cazacu, I. M. et al. Pancreatitis-associated genes and pancreatic cancer risk: a systematic review and meta-analysis. Pancreas 47, 1078\u20131086 (2018).","journal-title":"Pancreas"},{"key":"57520_CR43","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1097\/MPA.0000000000000166","volume":"43","author":"S Schubert","year":"2014","unstructured":"Schubert, S. et al. CFTR, SPINK1, PRSS1, and CTRC mutations are not associated with pancreatic cancer in German patients. Pancreas 43, 1078\u20131082 (2014).","journal-title":"Pancreas"},{"key":"57520_CR44","doi-asserted-by":"publisher","first-page":"6343","DOI":"10.3748\/wjg.v12.i39.6343","volume":"12","author":"A Piepoli","year":"2006","unstructured":"Piepoli, A. et al. Lack of association between UGT1A7, UGT1A9, ARP, SPINK1 and CFTR gene polymorphisms and pancreatic cancer in Italian patients. World J. Gastroenterol. 12, 6343\u20136348 (2006).","journal-title":"World J. Gastroenterol."},{"key":"57520_CR45","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1159\/000348439","volume":"87","author":"C Hamoir","year":"2013","unstructured":"Hamoir, C. et al. Clinical and morphological characteristics of sporadic genetically determined pancreatitis as compared to idiopathic pancreatitis: higher risk of pancreatic cancer in CFTR variants. Digestion 87, 229\u2013239 (2013).","journal-title":"Digestion"},{"key":"57520_CR46","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1002\/cncr.24697","volume":"116","author":"RR McWilliams","year":"2010","unstructured":"McWilliams, R. R. et al. Cystic fibrosis transmembrane conductance regulator (CFTR) gene mutations and risk for pancreatic adenocarcinoma. Cancer 116, 203\u2013209 (2010).","journal-title":"Cancer"},{"key":"57520_CR47","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/nature11003","volume":"483","author":"J Barretina","year":"2012","unstructured":"Barretina, J. et al. The cancer cell line encyclopedia enables predictive modelling of anticancer drug sensitivity. Nature 483, 603\u2013607 (2012).","journal-title":"Nature"},{"key":"57520_CR48","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1242\/jcs.105.2.417","volume":"105","author":"JA Chambers","year":"1993","unstructured":"Chambers, J. A. & Harris, A. Expression of the cystic fibrosis gene and the major pancreatic mucin gene, MUC1, in human ductal epithelial cells. J. Cell Sci. 105, 417\u2013422 (1993).","journal-title":"J. Cell Sci."},{"key":"57520_CR49","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/0092-8674(95)90240-6","volume":"83","author":"CL Ward","year":"1995","unstructured":"Ward, C. L., Omura, S. & Kopito, R. R. Degradation of CFTR by the ubiquitin-proteasome pathway. Cell 83, 121\u2013127 (1995).","journal-title":"Cell"},{"key":"57520_CR50","doi-asserted-by":"publisher","first-page":"3504","DOI":"10.1038\/onc.2017.3","volume":"36","author":"BLN Than","year":"2017","unstructured":"Than, B. L. N. et al. CFTR is a tumor suppressor gene in murine and human intestinal cancer. Oncogene 36, 3504 (2017).","journal-title":"Oncogene"},{"key":"57520_CR51","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1016\/j.ygeno.2019.06.028","volume":"112","author":"PT Ikpa","year":"2020","unstructured":"Ikpa, P. T. et al. Transcriptome analysis of the distal small intestine of Cftr null mice. Genomics 112, 1139\u20131150 (2020).","journal-title":"Genomics"},{"key":"57520_CR52","doi-asserted-by":"crossref","unstructured":"Declercq, M. et al. Transcriptomic analysis of CFTR-impaired endothelial cells reveals a pro-inflammatory phenotype. Eur. Respir. J. 57, 2000261 (2021).","DOI":"10.1183\/13993003.00261-2020"},{"key":"57520_CR53","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1016\/j.cmet.2022.09.023","volume":"34","author":"M Martin-Perez","year":"2022","unstructured":"Martin-Perez, M., Urdiroz-Urricelqui, U., Bigas, C. & Benitah, S. A. The role of lipids in cancer progression and metastasis. Cell Metab.34, 1675\u20131699 (2022).","journal-title":"Cell Metab."},{"key":"57520_CR54","doi-asserted-by":"crossref","unstructured":"Tutino, V. et al. Elevated AA\/EPA ratio represents an inflammatory biomarker in tumor tissue of metastatic colorectal cancer patients. Int. J. Mol. Sci. 20, 2050 (2019).","DOI":"10.3390\/ijms20082050"},{"key":"57520_CR55","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1203\/01.PDR.0000049937.30305.8A","volume":"53","author":"H Dombrowsky","year":"2003","unstructured":"Dombrowsky, H., Clark, G. T., Rau, G. A., Bernhard, W. & Postle, A. D. Molecular species compositions of lung and pancreas phospholipids in the cftr(tm1HGU\/tm1HGU) cystic fibrosis mouse. Pediatric Res. 53, 447\u2013454 (2003).","journal-title":"Pediatric Res."},{"key":"57520_CR56","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1038\/s41586-018-0198-8","volume":"558","author":"X Que","year":"2018","unstructured":"Que, X. et al. Oxidized phospholipids are proinflammatory and proatherogenic in hypercholesterolaemic mice. Nature 558, 301\u2013306 (2018).","journal-title":"Nature"},{"key":"57520_CR57","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.cell.2008.02.043","volume":"133","author":"Y Imai","year":"2008","unstructured":"Imai, Y. et al. Identification of oxidative stress and Toll-like receptor 4 signaling as a key pathway of acute lung injury. Cell 133, 235\u2013249 (2008).","journal-title":"Cell"},{"key":"57520_CR58","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-29857-6","volume":"13","author":"X Shi","year":"2022","unstructured":"Shi, X. et al. Integrated profiling of human pancreatic cancer organoids reveals chromatin accessibility features associated with drug sensitivity. Nat. Commun. 13, 2169 (2022).","journal-title":"Nat. Commun."},{"key":"57520_CR59","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1056\/NEJMoa1917239","volume":"383","author":"DS Hong","year":"2020","unstructured":"Hong, D. S. et al. KRAS(G12C) inhibition with sotorasib in advanced solid tumors. N. Engl. J. Med. 383, 1207\u20131217 (2020).","journal-title":"N. Engl. J. Med."},{"key":"57520_CR60","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1056\/NEJMoa2204619","volume":"387","author":"PA Janne","year":"2022","unstructured":"Janne, P. A. et al. Adagrasib in non-small-cell lung cancer harboring a KRAS(G12C) mutation. N. Engl. J. Med. 387, 120\u2013131 (2022).","journal-title":"N. Engl. J. Med."},{"key":"57520_CR61","doi-asserted-by":"publisher","first-page":"S23","DOI":"10.1002\/ppul.23553","volume":"51","author":"JM Beekman","year":"2016","unstructured":"Beekman, J. M. Individualized medicine using intestinal responses to CFTR potentiators and correctors. Pediatr. Pulmonol. 51, S23\u2013S34 (2016).","journal-title":"Pediatr. Pulmonol."},{"key":"57520_CR62","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2020.102675","volume":"53","author":"J Earl","year":"2020","unstructured":"Earl, J. et al. A comprehensive analysis of candidate genes in familial pancreatic cancer families reveals a high frequency of potentially pathogenic germline variants. EBioMedicine 53, 102675 (2020).","journal-title":"EBioMedicine"},{"key":"57520_CR63","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2021.103446","volume":"69","author":"M Yang","year":"2021","unstructured":"Yang, M. et al. DAGM: A novel modelling framework to assess the risk of HER2-negative breast cancer based on germline rare coding mutations. EBioMedicine 69, 103446 (2021).","journal-title":"EBioMedicine"},{"key":"57520_CR64","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1038\/nature12981","volume":"505","author":"N Rahman","year":"2014","unstructured":"Rahman, N. Realizing the promise of cancer predisposition genes. Nature 505, 302\u2013308 (2014).","journal-title":"Nature"},{"key":"57520_CR65","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1093\/bioinformatics\/btp324","volume":"25","author":"H Li","year":"2009","unstructured":"Li, H. & Durbin, R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 25, 1754\u20131760 (2009).","journal-title":"Bioinformatics"},{"key":"57520_CR66","doi-asserted-by":"crossref","first-page":"11 10 11","DOI":"10.1002\/0471250953.bi1110s43","volume":"43","author":"GA Van der Auwera","year":"2013","unstructured":"Van der Auwera, G. A. et al. From FastQ data to high confidence variant calls: the Genome analysis toolkit best practices pipeline. Curr. Protoc. Bioinform. 43, 11 10 11\u201311 10 33 (2013).","journal-title":"Curr. Protoc. Bioinform."},{"key":"57520_CR67","doi-asserted-by":"publisher","unstructured":"Poplin, R. et al. Scaling accurate genetic variant discovery to tens of thousands of samples. bioRxiv https:\/\/doi.org\/10.1101\/201178 (2018).","DOI":"10.1101\/201178"},{"key":"57520_CR68","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1101\/gr.129684.111","volume":"22","author":"DC Koboldt","year":"2012","unstructured":"Koboldt, D. C. et al. VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing. Genome Res. 22, 568\u2013576 (2012).","journal-title":"Genome Res."},{"key":"57520_CR69","doi-asserted-by":"publisher","first-page":"D1062","DOI":"10.1093\/nar\/gkx1153","volume":"46","author":"MJ Landrum","year":"2018","unstructured":"Landrum, M. J. et al. ClinVar: improving access to variant interpretations and supporting evidence. Nucleic Acids Res. 46, D1062\u2013D1067 (2018).","journal-title":"Nucleic Acids Res."},{"key":"57520_CR70","doi-asserted-by":"publisher","unstructured":"Chen, S. et al. A genome-wide mutational constraint map quantified from variation in 76,156 human genomes. bioRxiv https:\/\/doi.org\/10.1101\/2022.03.20.485034 (2022).","DOI":"10.1101\/2022.03.20.485034"},{"key":"57520_CR71","doi-asserted-by":"publisher","first-page":"3812","DOI":"10.1093\/nar\/gkg509","volume":"31","author":"PC Ng","year":"2003","unstructured":"Ng, P. C. & Henikoff, S. SIFT: Predicting amino acid changes that affect protein function. Nucleic Acids Res. 31, 3812\u20133814 (2003).","journal-title":"Nucleic Acids Res."},{"key":"57520_CR72","doi-asserted-by":"publisher","DOI":"10.1186\/s13040-017-0126-8","volume":"10","author":"S Kim","year":"2017","unstructured":"Kim, S., Jhong, J. H., Lee, J. & Koo, J. Y. Meta-analytic support vector machine for integrating multiple omics data. BioData Min. 10, 2 (2017).","journal-title":"BioData Min."},{"key":"57520_CR73","doi-asserted-by":"publisher","first-page":"D886","DOI":"10.1093\/nar\/gky1016","volume":"47","author":"P Rentzsch","year":"2019","unstructured":"Rentzsch, P., Witten, D., Cooper, G. M., Shendure, J. & Kircher, M. CADD: predicting the deleteriousness of variants throughout the human genome. Nucleic acids Res. 47, D886\u2013d894 (2019).","journal-title":"Nucleic acids Res."},{"key":"57520_CR74","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/nbt.2514","volume":"31","author":"K Cibulskis","year":"2013","unstructured":"Cibulskis, K. et al. Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nat Biotechnol. 31, 213\u2013219 (2013).","journal-title":"Nat Biotechnol."},{"key":"57520_CR75","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1093\/bioinformatics\/btr670","volume":"28","author":"V Boeva","year":"2012","unstructured":"Boeva, V. et al. Control-FREEC: a tool for assessing copy number and allelic content using next-generation sequencing data. Bioinformatics 28, 423\u2013425, (2012).","journal-title":"Bioinformatics"},{"key":"57520_CR76","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms10086","volume":"6","author":"C Lu","year":"2015","unstructured":"Lu, C. et al. Patterns and functional implications of rare germline variants across 12 cancer types. Nat. Commun. 6, 10086 (2015).","journal-title":"Nat. Commun."},{"key":"57520_CR77","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2011-12-4-r41","volume":"12","author":"CH Mermel","year":"2011","unstructured":"Mermel, C. H. et al. GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers. Genome Biol.12, R41 (2011).","journal-title":"Genome Biol."},{"key":"57520_CR78","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1038\/s41587-019-0201-4","volume":"37","author":"D Kim","year":"2019","unstructured":"Kim, D., Paggi, J. M., Park, C., Bennett, C. & Salzberg, S. L. Graph-based genome alignment and genotyping with HISAT2 and HISAT-genotype. Nat. Biotechnol. 37, 907\u2013915 (2019).","journal-title":"Nat. Biotechnol."},{"key":"57520_CR79","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1093\/bioinformatics\/btt656","volume":"30","author":"Y Liao","year":"2014","unstructured":"Liao, Y., Smyth, G. K. & Shi, W. featureCounts: an efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics 30, 923\u2013930 (2014).","journal-title":"Bioinformatics"},{"key":"57520_CR80","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1093\/bioinformatics\/btp616","volume":"26","author":"MD Robinson","year":"2010","unstructured":"Robinson, M. D., McCarthy, D. J. & Smyth, G. K. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 26, 139\u2013140 (2010).","journal-title":"Bioinformatics"},{"key":"57520_CR81","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1016\/j.ccell.2021.04.014","volume":"39","author":"A Bagaev","year":"2021","unstructured":"Bagaev, A. et al. Conserved pan-cancer microenvironment subtypes predict response to immunotherapy. Cancer Cell 39, 845\u2013865.e847 (2021).","journal-title":"Cancer Cell"},{"key":"57520_CR82","doi-asserted-by":"crossref","unstructured":"Danecek, P. et al. Twelve years of SAMtools and BCFtools. Gigascience 10, giab008 (2021).","DOI":"10.1093\/gigascience\/giab008"},{"key":"57520_CR83","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2008-9-9-r137","volume":"9","author":"Y Zhang","year":"2008","unstructured":"Zhang, Y. et al. Model-based analysis of ChIP-Seq (MACS). Genome Biol. 9, R137 (2008).","journal-title":"Genome Biol."},{"key":"57520_CR84","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1016\/j.surg.2020.02.013","volume":"168","author":"SW Guo","year":"2020","unstructured":"Guo, S. W. et al. A preoperative risk model for early recurrence after radical resection may facilitate initial treatment decisions concerning the use of neoadjuvant therapy for patients with pancreatic ductal adenocarcinoma. Surgery 168, 1003\u20131014 (2020).","journal-title":"Surgery"},{"key":"57520_CR85","doi-asserted-by":"publisher","DOI":"10.1186\/s40001-019-0365-x","volume":"24","author":"M Malsy","year":"2019","unstructured":"Malsy, M., Bitzinger, D., Graf, B. & Bundscherer, A. Staurosporine induces apoptosis in pancreatic carcinoma cells PaTu 8988t and Panc-1 via the intrinsic signaling pathway. Eur. J. Med. Res. 24, 5 (2019).","journal-title":"Eur. J. Med. Res."},{"key":"57520_CR86","doi-asserted-by":"publisher","first-page":"4281","DOI":"10.1021\/ac051632c","volume":"78","author":"F Dieterle","year":"2006","unstructured":"Dieterle, F., Ross, A., Schlotterbeck, G. & Senn, H. Probabilistic quotient normalization as robust method to account for dilution of complex biological mixtures. Application in 1H NMR metabonomics. Anal. Chem. 78, 4281\u20134290 (2006).","journal-title":"Anal. Chem."},{"key":"57520_CR87","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1038\/nprot.2011.335","volume":"6","author":"WB Dunn","year":"2011","unstructured":"Dunn, W. B. et al. Procedures for large-scale metabolic profiling of serum and plasma using gas chromatography and liquid chromatography coupled to mass spectrometry. Nat. Protoc. 6, 1060\u20131083 (2011).","journal-title":"Nat. Protoc."},{"key":"57520_CR88","unstructured":"Yin, X. et al. Pathogenic germline variants in Chinese pancreatic adenocarcinoma patients. code ocean. JAMA Netw. Open 5, e2148721 (2024)."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-57520-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-57520-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-57520-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T16:01:05Z","timestamp":1741190465000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-57520-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,5]]},"references-count":88,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["57520"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-57520-3","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,5]]},"assertion":[{"value":"21 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2214"}}